The economic burden of noncervical human papillomavirus disease in the United States.

[1]  W. Geisler,et al.  Chlamydial and gonococcal infections in women seeking pregnancy testing at family-planning clinics. , 2008, American journal of obstetrics and gynecology.

[2]  C. Cardinez,et al.  United States cancer statistics; 2003 incidence and mortality , 2006 .

[3]  R. Fleurence,et al.  Review of the economic and quality-of-life burden of cervical human papillomavirus disease. , 2006, American journal of obstetrics and gynecology.

[4]  C. Lacey,et al.  Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. , 2006, Vaccine.

[5]  D. Harper,et al.  Chapter 13: Current findings from prophylactic HPV vaccine trials. , 2006, Vaccine.

[6]  F. Bray,et al.  Chapter 2: The burden of HPV-related cancers. , 2006, Vaccine.

[7]  D. Wiley,et al.  Human papillomavirus: the burden of infection. , 2006, Obstetrical & gynecological survey.

[8]  M C Downer,et al.  The cost-effectiveness of screening for oral cancer in primary care. , 2006, Health technology assessment.

[9]  C. J. Colby,et al.  Cost analysis of neonatal circumcision in a large health maintenance organization. , 2006, The Journal of urology.

[10]  S. Franceschi,et al.  Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review , 2005, Cancer Epidemiology Biomarkers & Prevention.

[11]  C. Earle,et al.  The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data. , 2004, Archives of otolaryngology--head & neck surgery.

[12]  R. S. Howe.  A cost-utility analysis of neonatal circumcision. , 2004 .

[13]  P. Porter,et al.  Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer , 2004, Cancer.

[14]  P. Maisonneuve,et al.  Carcinoma of the vulva , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[15]  S. Sonnad,et al.  Cost-Effectiveness of Pap Smear Screening for Vaginal Cancer After Total Hysterectomy for Benign Disease , 2003, Journal of lower genital tract disease.

[16]  E. Dasbach,et al.  The health and economic burden of genital warts in a set of private health plans in the United States. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  P. Porter,et al.  A population-based study of squamous cell vaginal cancer: HPV and cofactors. , 2002, Gynecologic oncology.

[18]  M. Rubin,et al.  Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. , 2001, The American journal of pathology.

[19]  R. Grimalt,et al.  Delusional hyperhidrosis as a risk for medical overtreatment: a case of botulinophilia. , 2001 .

[20]  K. Shah,et al.  The cost of juvenile-onset recurrent respiratory papillomatosis. , 2000, Archives of otolaryngology--head & neck surgery.

[21]  W. Reeves,et al.  Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  M. Weinstein,et al.  Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. , 2000, The American journal of medicine.

[23]  H. Adami,et al.  Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. , 1999, Cancer research.

[24]  M. Lehtinen,et al.  Human Papillomavirus in Squamous Cell Carcinoma of the Vulva by Polymerase Chain Reaction , 1997, Obstetrics and gynecology.

[25]  L. Brinton,et al.  Heterogeneous etiology of squamous carcinoma of the vulva , 1996, Obstetrics and gynecology.

[26]  C. Derkay.  Task force on recurrent respiratory papillomas. A preliminary report. , 1995, Archives of otolaryngology--head & neck surgery.

[27]  E. Keeler,et al.  Costing Medical Care: Using Medicare Administrative Data , 1994, Medical care.

[28]  M. Pollack,et al.  Home care cost-effectiveness for respiratory technology-dependent children. , 1991, American journal of diseases of children.

[29]  S. Isomura,et al.  A comparative trial of the reactogenicity and immunogenicity of Takeda acellular pertussis vaccine combined with tetanus and diphtheria toxoids. Outcome in 3- to 8-month-old infants, 9- to 23-month-old infants and children, and 24- to 30-month-old children. , 1991, American journal of diseases of children.

[30]  Guoyu Tao,et al.  The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. , 2004, Perspectives on sexual and reproductive health.

[31]  S. Dahrouge,et al.  Lifetime costs of colon and rectal cancer management in Canada. , 2003, Chronic diseases in Canada.

[32]  C. R. Leemans,et al.  The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up. , 2001, European journal of cancer.

[33]  P. Langley,et al.  The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts. , 1999, The American journal of managed care.